You searched for "invasive"

816 results found

Surgitrac Instruments is pleased to welcome back Scott Shipley as our new Clinical Representative for the Midlands region.

Sugitac Instruments is delighted to announce the addition of Scott Shipley as our new Clinical Representative for the Midlands region. Scott brings a strong passion for ophthalmology, a dedication to client relations, and a wealth of expertise that make him...

Glaukos & Glaucoma UK join forces to visit Westminster

To mark Glaucoma Awareness Week 2025, a parliamentary drop-in session was held on Wednesday, 2nd July at Portcullis House, Westminster. Hosted by Steve Darling MP and supported by Glaucoma UK and Glaukos UK, the event brought together parliamentarians, clinicians, and...

Surgitrac confirms 2026 events so far

Surgitrac Instruments is delighted to announce the first confirmed meetings for our 2026 events calendar, where our team will once again be out on the road meeting ophthalmic professionals across the UK. Our Clinical Specialists will be representing Surgitrac at...

Graham Popham joins Glaukos as Senior Director, Market Access EMEAI

Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’I'm excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...

Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect membership

Heidelberg Engineering announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica’s Vision Architect membership – CCOI’s highest level of industry participation. CCOI is a public–private forum that convenes patients, clinicians,...

Mainline Instruments opens expanded head office to support growth and customer excellence

Mainline Instruments is pleased to announce the opening of its newly expanded head office facility, marking a significant milestone in the company’s continued growth and commitment to excellence. The expansion introduces additional office space, a modern showroom, and purpose-built educational...

Up Close and Visible: Correcting Global Presbyopia

International Centre for Eye Health Webinar

Biomarkers reveal how patients with glaucoma may respond to treatment

Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.

Clinical trial investigates ‘Light Touch’ approach to wet AMD treatment

A clinical trial led by NIHR Moorfields Clinical Research Facility will explore a new ‘light-touch’ treatment approach for patients with neovascular age-related macular degeneration (wet AMD) that could result in fewer injections and reduced number of clinic visits. Funded by...

New NHS study highlights ways to help patients with painful, slow-healing corneal wounds recover sooner

Teams at Queen Victoria Hospital NHS Foundation Trust (QVH) and Maidstone and Tunbridge Wells NHS Trust (MTW) have published new findings highlighting how long and demanding treatment can be for people with persistent corneal epithelial defects and how a clinic-based...

An uncommon late postoperative complication of combined cataract surgery and intravitreal triamcinolone injection

Case report A 64-year-old female with diabetic maculopathy (DMO) underwent phacoemulsification with intraocular lens (IOL) implantation in her right eye combined with intravitreal triamcinolone (IVTA). Diabetes control was poor with HbA1c (IFCC) of 119mmol/mol and blood sugar level of 27mmol/L....

Redefining the future of sight - Moorfields Eye Charity launches first major national funding initiative

New grants strategy aims to enable innovation at scale and transform eye health. Moorfields Eye Charity has launched a significant national funding initiative to accelerate the urgent development of new eye health treatments and interventions. The new Discovery and Translation...